Target-controlled naloxone-infusion
MP_SM01_2013
Phase 2 small_molecule completed
Quick answer
Target-controlled naloxone-infusion for Central Nervous System Sensitization is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Central Nervous System Sensitization
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed